RNA Binding Proteins as Drivers and Therapeutic Target Candidates in Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinomas (PDAC) belong to the most frequent and most deadly malignancies in the western world. Mutations in KRAS and TP53 along with some other frequent polymorphisms occur almost universally and are likely to be responsible for tumor initiation. However, these mutations can...
Main Authors: | Markus Glaß, Patrick Michl, and Stefan Hüttelmaier |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/11/4190 |
Similar Items
-
Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in cancer
by: Xinwei Huang, et al.
Published: (2018-06-01) -
Expression and prognostic analyses of the insulin-like growth factor 2 mRNA binding protein family in human pancreatic cancer
by: Xiao-Han Cui, et al.
Published: (2020-11-01) -
Serum levels of IGF-1 and IGF-BP3 are associated with event-free survival in adult Ewing sarcoma patients treated with chemotherapy
by: de Groot S, et al.
Published: (2017-06-01) -
IGF2BP1, a Conserved Regulator of RNA Turnover in Cancer
by: Markus Glaß, et al.
Published: (2021-03-01) -
Bone metastasis as primary presentation of pancreatic ductal adenocarcinoma: A case report and literature review
by: Antonella Argentiero, et al.
Published: (2019-10-01)